+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Occupational Medicines Market by Application and Industry: Global Opportunity Analysis and Industry Forecast up to 2027

  • PDF Icon

    Report

  • 210 Pages
  • July 2023
  • Region: Global
  • IHR Insights
  • ID: 5850109
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The occupational medicines market refers to the segment of the healthcare industry that focuses on providing medical services and solutions for workplace-related health issues. This includes the prevention, diagnosis, and treatment of work-related injuries and illnesses. Stringent occupational health and safety regulations implemented by governments and regulatory bodies across the world drive the demand for occupational medicines. Employers are required to provide a safe and healthy work environment for their employees, including appropriate medical surveillance and preventive measures. Compliance with these regulations necessitates the use of occupational medicines to assess and manage occupational hazards. On the other hand, the cost of implementing comprehensive occupational health programs and lack of awareness and education on occupational medicines may limit the market growth. Occupational Medicines Market is likely to grow at a rate of 6.6% CAGR by 2027.

Occupational Medicines Market by Application

  • Chemical poisoning
  • Psychological disorder
  • Non-Induced hearing loss & vibration
  • Skin disorder
  • Chronic respiratory disease
  • Pneumoconiosis
  • Musculoskeletal disorder
  • Cancer

Occupational Medicines Market by Industry

  • Agriculture & forestry
  • Construction
  • Manufacturing
  • Petroleum & mining
  • Transportation

Occupational Medicines Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
In the market for application, the Occupational Medicines market is segmented into Chemical poisoning, Psychological disorder, Non-Induced hearing loss & vibration, Skin disorder, chronic respiratory disease, Pneumoconiosis, Musculoskeletal disorder and Cancer. Among them the chronic respiratory disease segment is likely to hold the significant share in the market. This is accredited to the rising number of respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and silicosis across the world. Work-related respiratory diseases are several illnesses caused by breathing in hazardous substances that damage the lungs, such as dust, fumes, and gases. Occupational lung disease has been adding to respiratory distress.

Key factors driving the occupational medicines market include:

Occupational Health and Safety Regulations: Governments and regulatory bodies across the world have implemented stringent occupational health and safety regulations to ensure worker safety. Compliance with these regulations necessitates the use of occupational medicines to prevent and treat work-related health conditions.

Growing Awareness: There is an increasing awareness among employers about the importance of maintaining a healthy workforce. Occupational medicines play a crucial role in promoting employee well-being, reducing absenteeism, and improving productivity.

Rising Incidence of Occupational Diseases: Work-related illnesses, such as respiratory disorders, musculoskeletal injuries, and chemical exposures, are on the rise. This has created a demand for occupational medicines that can address these specific health concerns.

Expansion of Industrial Sectors: As various industries continue to expand, the number of workers exposed to occupational hazards also increases. This further drives the need for occupational medicines to ensure employee health and safety.

Technological Advancements: Advancements in medical technology have led to the development of innovative diagnostic tools, treatments, and preventive measures for occupational diseases. This has contributed to the growth of the occupational medicines market.

The major leading companies of the Occupational Medicines market are Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Nestlé S.A. (Galderma S.A.), Novartis AG, Pfizer Inc., Sanofi.

The market for occupational medicines includes various products and services, such as medical examinations, health screenings, vaccinations, drug testing, and treatment of work-related injuries and illnesses. It encompasses both pharmaceutical products specific to occupational health and broader medical services provided by occupational health professionals.

It's important to note that market trends and dynamics can change over time. Therefore, for the most up-to-date information on the current state of the occupational medicines market, it is advisable to consult recent market research reports, industry publications, and reach out to relevant stakeholders in the occupational health sector.

Key reasons to purchase the report:

  • Comprehensive overview of the global Occupational Medicines market restrains, opportunities, challenges, expected to drive its market growth.
  • The report provides the in-depth market segmentation along with the past, present and estimated market size in terms of volume and value.
  • This report presents the current industry trends and developments and the competitive outlook and strategies of key players and product offerings.
  • This report also depicts the SWOT analysis, portfolio analysis, capability analysis of the leading competitors.

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Application: Market Size & Analysis
5.1. Chemical poisoning
5.2. Psychological disorder
5.3. Non-Induced hearing loss & vibration
5.4. Skin disorder
5.5. Chronic respiratory disease
5.6. Pneumoconiosis
5.7. Musculoskeletal disorder
5.8. Cancer
6. Industry: Market Size & Analysis
6.1. Agriculture & forestry
6.2. Construction
6.3. Manufacturing
6.4. Petroleum & mining
6.5. Transportation
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. ELI LILLY AND COMPANY.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. ASTRAZENECA PLC,
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Novartis AG
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. JOHNSON & JOHNSON.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. BRISTOL-MYERS SQUIBB COMPANY,
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.5.6. Business Strategy
9.6. F. HOFFMANN-LA ROCHE LTD
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. PFIZER IN
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Amgen Inc.
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. SANOFI.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Nestlé S.A
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

Companies Mentioned

  • ELI LILLY AND COMPANY.
  • ASTRAZENECA PLC,
  • Novartis AG
  • JOHNSON & JOHNSON.
  • BRISTOL-MYERS SQUIBB COMPANY,
  • F. HOFFMANN-LA ROCHE LTD
  • PFIZER IN
  • Amgen Inc.
  • SANOFI.
  • Nestlé S.A